Simply login to your account on syrona.org and go to your subscriptions tab in your back office to make any necessary changes
Persistence of newer anti-obesity medications in a real-world setting
AMPK can phosphorylate the T79 site of ACC, rendering it inactive and thereby reducing lipid deposition
This uniquely integrated capability incorporates CordenPharmas extensive experience in large-scale peptide drug substance, sterile injectable fill-finish, and oral solid dosage manufacturing
CrossRef BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy Gidon J Bnhof, Gundega Sipola, Alexander Strom, Christian Herder, Klaus Strassburger, Birgit Knebel, Claudia Reule, Jan-Christoph Wollmann, Andrea Icks, Hadi Al-Hasani, Michael Roden, Oliver Kuss, Dan Ziegler BMJ Open.2022